v3.26.1
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share
Potentially dilutive securities, not included in the calculation of diluted net loss per share attributable to common stockholders because to do so would be anti-dilutive, are as follows:
As of June 30,
20262025
Options to purchase common stock6,150,494 2,585,361 
Placement agent warrants28,333 28,333 
Time based Stock Appreciation Rights496,679 — 
Stock Appreciation Rights from exercised Series B Warrants23,077 — 
Potential additional Stock Appreciation Rights from Series B Warrants384,694 — 
February 2026 common warrants22,907,600 — 
Series B Warrants3,357,967 — 
33,348,844 2,613,694